News
California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom’s proposed cuts, when Ozempic is ...
For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But ...
The "most obvious culprit" behind the company's "dramatic change in fortunes" is the rise of Ozempic and similar drugs, which ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
At its peak, WeightWatchers was seen as being synonymous with safe and controlled weight loss. With 4.5million subscribers ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results